StemCells (STEM) Reports In-Line Q2 EPS

StemCells, Inc. Reports Second Quarter 2015 Financial Results, Business Update and Clinical Program Highlights

NEWARK, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ: STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the central nervous system, today reported its financial results for the three months ended June 30, 2015. The Company also provided a business update and clinical program highlights for the quarter.

"Our clinical programs achieved several key milestones since our last earnings release," reported StemCells CEO Martin McGlynn. "Based on the strength of the safety and preliminary efficacy data from our Phase I/II clinical studies, our... More

R. Scott Greer Joins Inogen Board of Directors

GOLETA, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that R. Scott Greer has been appointed as an independent director to its Board of Directors, effective August 3, 2015. In addition, Mr. Greer was appointed to the Board's Audit Committee. He will serve as a Class I director, with a term expiring at the annual... More

R. Scott Greer Joins Inogen Board of Directors

GOLETA, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that R. Scott Greer has been appointed as an independent director to its Board of Directors, effective August 3, 2015. In addition, Mr. Greer was appointed to the Board's Audit Committee. He will serve as a Class I director, with a term expiring at the annual... More